A Follow-up Study to Investigate the Effects of a New Infant Formula on Growth and Body Composition

A Follow-up Study of a Randomised, Controlled, Study to Investigate the Effects of a New Infant Formula Given in the First 12 Months of Life on Growth and Body Composition up to 5 Years of Age

A follow-up study of a randomised, controlled, study to investigate the effects of a new infant formula given in the first 12 months of life on growth and body composition up to 5 years of age

A follow-up study of a randomised, controlled, study to investigate the effects of a new infant formula given in the first 12 months of life on growth and body composition up to 5 years of age. Participants from Venus study will be invited to participate in this follow-up study.

Hypothesis: Significant difference in body mass index (BMI) development for subjects who had received infant formula and follow on formula with scGOS/lcFOS/Nuturis® compared to the control product scGOS/lcFOS and standard formula. No significant difference in growth of subjects who had received infant formula and follow on formula with scGOS/lcFOS/Nuturis® compared to the breast-feeding reference group.

Inclusion Criteria:

• Participation in the intervention period of VENUS study until 12 months of age or participation in the VENUS study as breast-fed reference group
• Written informed consent from parent(s) or legally acceptable representatives

Exclusion Criteria:

• Investigator's uncertainty about the willingness or ability of the child and parents to comply with the protocol requirements